Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Lemaitre Vascular (LMAT) Equity Average (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Equity Average for 15 consecutive years, with $386.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Equity Average rose 15.57% to $386.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $386.2 million, a 15.57% increase, with the full-year FY2025 number at $365.4 million, up 15.05% from a year prior.
  • Equity Average was $386.2 million for Q4 2025 at Lemaitre Vascular, up from $370.8 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $386.2 million in Q4 2025 to a low of $175.0 million in Q1 2021.
  • A 5-year average of $286.2 million and a median of $282.6 million in 2023 define the central range for Equity Average.
  • Peak YoY movement for Equity Average: soared 50.86% in 2021, then rose 5.22% in 2022.
  • Lemaitre Vascular's Equity Average stood at $251.6 million in 2021, then increased by 5.22% to $264.7 million in 2022, then grew by 10.78% to $293.3 million in 2023, then grew by 13.95% to $334.2 million in 2024, then increased by 15.57% to $386.2 million in 2025.
  • Per Business Quant, the three most recent readings for LMAT's Equity Average are $386.2 million (Q4 2025), $370.8 million (Q3 2025), and $355.1 million (Q2 2025).